BioCorRx Inc.: 10-Q filed 2022-08-15

Name: BioCorRx Inc.: 10-Q filed 2022-08-15
Creator: BioCorRx Inc.

What BioCorRx Inc. reported in its quarterly report filed 2022-08-15 (fiscal Q2 2022): 36 published measures, 101 facts as tagged in accession 0001477932-22-006035.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-08-15
Fiscal period: fiscal Q2 2022
Accession: 0001477932-22-006035 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioCorRx Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-06-30	890,055	USD
At 2021-12-31	819,975	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-06-30	8,351,613	USD
At 2021-12-31	7,781,451	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-06-30	-7,341,413	USD
At 2022-03-31	-6,753,555	USD
At 2021-12-31	-6,843,638	USD
At 2021-06-30	-4,491,381	USD
At 2021-03-31	-3,486,162	USD
At 2020-12-31	-4,210,353	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2022-06-30	111,461	USD
At 2021-12-31	85,838	USD
At 2021-06-30	703,158	USD
At 2020-12-31	592,053	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-1,317,819	USD	91
2022-01-01 to 2022-06-30	-2,262,810	USD	181
2022-01-01 to 2022-03-31	-944,991	USD	90
2021-04-01 to 2021-06-30	-1,061,905	USD	91
2021-01-01 to 2021-06-30	-2,645,968	USD	181
2021-01-01 to 2021-03-31	-1,584,063	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-1,224,377	USD	181
2021-01-01 to 2021-06-30	-2,268,318	USD	181
2021-01-01 to 2021-03-31	-930,089	USD	90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	16,002	USD	91
2022-01-01 to 2022-06-30	36,520	USD	181
2021-04-01 to 2021-06-30	15,718	USD	91
2021-01-01 to 2021-06-30	25,842	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	1,250,000	USD	181
2021-01-01 to 2021-06-30	2,381,440	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	-2,017	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-06-30	-72,227,195	USD
At 2021-12-31	-69,966,692	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	1,416,859	shares	181
2021-01-01 to 2021-06-30	1,073,631	shares	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-06-30	89,707	USD
At 2021-12-31	102,843	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	210,932	USD	181
2021-01-01 to 2021-06-30	114,940	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-1,358,356	USD	91
2022-01-01 to 2022-06-30	-2,483,030	USD	181
2021-04-01 to 2021-06-30	-963,406	USD	91
2021-01-01 to 2021-06-30	-2,542,622	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-06-30	368,063	USD
At 2021-12-31	228,326	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	100,326	USD	91
2022-01-01 to 2022-06-30	113,602	USD	181
2021-04-01 to 2021-06-30	870	USD	91
2021-01-01 to 2021-06-30	1,500	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-06-30	4,795,694	USD
At 2021-12-31	4,386,444	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-06-30	1,151,188	USD
At 2021-12-31	986,605	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	1,374,358	USD	91
2022-01-01 to 2022-06-30	2,519,550	USD	181
2021-04-01 to 2021-06-30	979,124	USD	91
2021-01-01 to 2021-06-30	2,568,464	USD	181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,725	USD	91
2022-01-01 to 2022-06-30	4,260	USD	181
2021-04-01 to 2021-06-30	1,796	USD	91
2021-01-01 to 2021-06-30	2,428	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	382,952	USD	91
2022-01-01 to 2022-06-30	580,801	USD	181
2021-04-01 to 2021-06-30	123,262	USD	91
2021-01-01 to 2021-06-30	781,499	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-06-30	7,082,285	shares
At 2021-12-31	6,698,968	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-06-30	64,757,084	USD
At 2021-12-31	62,994,739	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2022-06-30	-7,461,558	USD
At 2021-12-31	-6,961,476	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-06-30	328,990	USD
At 2021-12-31	384,921	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2022-06-30	250,291	USD
At 2021-12-31	315,672	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2022-06-30	194,551	USD
At 2021-12-31	194,551	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2022-06-30	104,844	USD
At 2021-12-31	91,708	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-2,262,810	USD	181
2021-01-01 to 2021-06-30	-2,645,968	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	981,819	USD	91
2022-01-01 to 2022-06-30	1,920,764	USD	181
2021-04-01 to 2021-06-30	834,726	USD	91
2021-01-01 to 2021-06-30	1,745,819	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	6,568	USD	91
2022-01-01 to 2022-06-30	13,136	USD	181
2021-04-01 to 2021-06-30	8,965	USD	91
2021-01-01 to 2021-06-30	14,548	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	40,537	USD	91
2022-01-01 to 2022-06-30	220,220	USD	181
2021-04-01 to 2021-06-30	-98,499	USD	91
2021-01-01 to 2021-06-30	-103,346	USD	181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	0	USD	181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	0	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	1,250,000	USD	181
2021-01-01 to 2021-06-30	2,250,000	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-11,465	USD	181
2021-01-01 to 2021-06-30	500	USD	181

Inspect the source

Entity: BioCorRx Inc. / CIK 0001443863
Captured: 2026-09-20T09:04:22.712Z
SEC response SHA-256: ac5d4257d7a196e773d03095d841b6e99a8b7a937efc54ce0410975e44478703

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443863.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))